Clinical trial
Gefitinib With or Without Simvastatin in Non-Small Cell Lung Cancer (NSCLC)
NCT00452244 · National Cancer Center, Korea, Other · Completed
Key facts
| NCT number | NCT00452244 |
|---|---|
| Title | Gefitinib With or Without Simvastatin in Non-Small Cell Lung Cancer (NSCLC) |
| Official title | Randomized Phase II Trail Comparing Gefitinib Plus Simvastatin and Gefitinib Alone in Patients With Previously Treated Advanced Non-Small Cell Lung Cancer (NSCLC) |
| Lead sponsor | National Cancer Center, Korea, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Drug |
| Interventions | simvastatin, gefitinib only |
| Enrollment | 110 |
| Start date | May 1, 2006 |
| Primary completion | Feb 1, 2011 |
| Completion | Mar 1, 2011 |
| First posted | Mar 27, 2007 |
| Last update posted | Aug 25, 2017 |
| Countries | South Korea |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: